[go: up one dir, main page]

HK1231748A1 - Aripiprazole formulations having increased injection speeds - Google Patents

Aripiprazole formulations having increased injection speeds Download PDF

Info

Publication number
HK1231748A1
HK1231748A1 HK17105402.2A HK17105402A HK1231748A1 HK 1231748 A1 HK1231748 A1 HK 1231748A1 HK 17105402 A HK17105402 A HK 17105402A HK 1231748 A1 HK1231748 A1 HK 1231748A1
Authority
HK
Hong Kong
Prior art keywords
injection speeds
increased injection
aripiprazole formulations
aripiprazole
formulations
Prior art date
Application number
HK17105402.2A
Other languages
Chinese (zh)
Inventor
B. HICKEY Migali
Vandiver Jennifer
Original Assignee
Alkermes Pharma Ireland Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alkermes Pharma Ireland Limited filed Critical Alkermes Pharma Ireland Limited
Publication of HK1231748A1 publication Critical patent/HK1231748A1/en

Links

Abstract

The present invention relates to pharmaceutical compositions comprising a compound of Formula (I) that are useful for the intramuscular delivery of antipsychotic drugs using rapid injection rates.
HK17105402.2A 2014-03-20 2015-03-19 Aripiprazole formulations having increased injection speeds HK1231748A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201461955976P 2014-03-20

Publications (1)

Publication Number Publication Date
HK1231748A1 true HK1231748A1 (en) 2017-12-29

Family

ID=

Similar Documents

Publication Publication Date Title
MX2020010839A (en) Aripiprazole formulations having increased injection speeds.
EP3302426A4 (en) D2o stabilized pharmaceutical formulations
HK1255102A1 (en) Heterocyclic compounds and uses thereof
EP3116492A4 (en) Pharmaceutical compositions of therapeutically active compounds
MX378732B (en) Solid forms
PH12020551586A1 (en) Oxysterols and methods of use thereof
EP3116491A4 (en) Pharmaceutical compositions of therapeutically active compounds
PH12016501517A1 (en) Tetrazolone-substituted dihydropyridinone mgat2 inhibitors
MX2015015562A (en) Dihydropyridinone mgat2 inhibitors.
MX2016013431A (en) Pharmaceutical compositions comprising antibacterial agents.
ZA201703562B (en) Pharmaceutical composition for oral administration comprising taxane
WO2014033526A9 (en) Pharmaceutical compositions of etoricoxib
EP3290037A4 (en) Pharmaceutical composition for oral administration
MX2017008074A (en) IMIDAZOPYRIDAZINE DERIVATIVES AS PI3Kß INHIBITORS.
WO2015181802A3 (en) Oral pharmaceutical composition of isotretinoin
WO2015191681A3 (en) Substituted pyridinones as mgat2 inhibitors
WO2016020408A3 (en) Compounds for preventing ototoxicity
MX2017008076A (en) Heterocyclyl linked imidazopyridazine derivatives as pi3kbeta inhibitors.
IN2014MU00859A (en)
IN2013MU03308A (en)
WO2014195977A3 (en) Novel polymorphs of vismodegib
HK1231748A1 (en) Aripiprazole formulations having increased injection speeds
MX2016013428A (en) Pharmaceutical compositions comprising antibacterial agents.
IN2013MU03309A (en)
EP3162368A4 (en) Pharmaceutical composition for oral administration